← Back to Search

Behavioral Intervention

Cognitive Training for Schizophrenia

Athens, GA
N/A
Recruiting
Research Sponsored by University of Georgia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 15 days or 30 days

Summary

This trial examines whether a cognitive training intervention can help improve emotion regulation in people with psychotic disorders. It is hypothesized that the cognitive training program will help by increasing activity in the prefrontal cortex, leading to better emotion regulation.

See full description
Who is the study for?
This trial is for adults aged 18-60 with a diagnosis of schizophrenia or schizoaffective disorder, who are clinically stable and have not changed their antipsychotic medication recently. Participants must speak English and have an IQ over 70. Those with recent substance abuse (except nicotine), significant brain injury, or neurological disorders cannot join.
What is being tested?
The study tests whether cognitive training can help people with psychotic disorders manage their emotions better. It involves two types of training: one that targets emotional working memory and another placebo version without this focus. The goal is to see if the targeted training improves brain function related to emotion regulation.See study design
What are the potential side effects?
Since the interventions involve non-invasive cognitive training exercises, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 15 days or 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 15 days or 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Prefrontal blood oxygen level dependent activation in the prefrontal cortex

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cognitive trainingExperimental Treatment1 Intervention
Emotional working memory training
Group II: Placebo trainingPlacebo Group1 Intervention
Placebo working memory training

Find a Location

Closest Location:University of Georgia· Athens, GA· 417 miles

Who is running the clinical trial?

University of GeorgiaLead Sponsor
108 Previous Clinical Trials
45,344 Total Patients Enrolled
2 Trials studying Schizophrenia
844 Patients Enrolled for Schizophrenia

Media Library

Emotional working memory training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04414215 — N/A
Schizophrenia Research Study Groups: Placebo training, Cognitive training
Schizophrenia Clinical Trial 2023: Emotional working memory training Highlights & Side Effects. Trial Name: NCT04414215 — N/A
Emotional working memory training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04414215 — N/A
~35 spots leftby Dec 2029